Skip to content
Open in App
Celltrion logo

Celltrion

web2

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale...

Symbol · 068270
Company profile

About

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin’s lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gastric cancer; Remsima SC and Yuflyma for rheumatoid arthritis and inflammatory bowel disease; Vegzelma for metastatic colorectal cancer and non-small cell lung cancer; Omlyclo for Asthma and urticaria; Eydenzelt for diabetic macular edema and wet age-related macular degeneration; Steqeyma for psoriasis and inflammatory bowel disease; Stoboclo/Osenvelt for osteoporosis; Avtozma for rheumatoid arthritis and active systemic juvenile idiopathic arthritis; Zymfentra for inflammatory bowel disease; and Regkirona for COVID-19, as well as CT-G07 for HIV/AIDS and Donerion Patch for Alzheimer's dementia symptoms. The company is also developing biosimilars, which are in Phase 3 clinical trials include CT-P44 for multiple myeloma, CT-P51 for melanoma and lung cancer, CT-P53 for multiple sclerosis, and CT-P55 for psoriasis, as well as CT-G20 for hypertrophic cardiomyopathy. It distributes its products in approximately 100 countries, including the United States and Europe. The company was founded in 2002 and is headquartered in Incheon, South Korea.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Begin KRW 100 billion share repurchase

KEY STEP

Celltrion plans to begin open market purchases of 524,384 treasury shares following the August 31 board approval, as part of its newly formalized shareholder return framework.

Roadmap reference
People

Company team

JS

Jung-Jin Seo

Inside Co-Chairman of the Board

Company leadership profile.

JS

Jin-Seok Seo

Co-CEO & Inside Co-Chairman of the Board

Company leadership profile.

WK

Woo-Sung Kee

Co-CEO & Internal Director

Company leadership profile.

MS

Min-Cheol Shin

CFO, Director of Finance & Inside Director

Company leadership profile.

YK

Young-hyeh Ko

Independent Director

Company leadership profile.

JM

Jong Moon Choi

Independent Director

Company leadership profile.

JJ

Joong Jae Lee

Independent Director

Company leadership profile.

WK

Won Kyung Choi

Independent Director

Company leadership profile.

TY

Tae-Hwa Yoon

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Celltrion.

Orbitrum research

Experts evaluating Celltrion

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment